News
HC Wainwright & Co. Reiterates Buy on Allogene Therapeutics, Maintains $10 Price Target
19 Mar 24
News, Price Target, Reiteration, Analyst Ratings
RBC Capital Reiterates Outperform on Allogene Therapeutics, Maintains $10 Price Target
15 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Recap: Allogene Therapeutics Q4 Earnings
14 Mar 24
Earnings
Allogene Therapeutics Q4 2023 GAAP EPS $(0.51) Misses $(0.46) Estimate, Sales $21.000K Miss $23.571K Estimate
14 Mar 24
Earnings, Earnings Misses, News
Earnings Scheduled For March 14, 2024
14 Mar 24
Earnings
Allogene Therapeutics Earnings Preview
13 Mar 24
Earnings
Allogene Therapeutics And Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement To Support Advancement Of Next-Generation Allogeneic CAR T Platform In Autoimmune Disease
12 Mar 24
Biotech, News, General
JP Morgan Maintains Overweight on Allogene Therapeutics, Lowers Price Target to $8
27 Feb 24
News, Price Target, Analyst Ratings
Allogene Therapeutics To Restate Previously Filed Financial Statements Related To The December 2020 Formation Of The Allogene Overland Biopharm Joint Venture In Asia; No Impact On Cash, Cash Equivalents And Marketable Investments, Cash Runway Or Business Operations
16 Feb 24
News, Management
CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday
12 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
HC Wainwright & Co. Maintains Buy on Allogene Therapeutics, Lowers Price Target to $10
19 Jan 24
News, Price Target, Analyst Ratings
Cell Therapy Focused Allogene Therapeutics' Resource Prioritization A Bold Move, Says Analyst
5 Jan 24
Analyst Color, Biotech, Equities, News, Penny Stocks, Health Care, Reiteration, Small Cap, Markets, Analyst Ratings, Movers, Trading Ideas, General
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
5 Jan 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Guggenheim Downgrades Allogene Therapeutics to Neutral
5 Jan 24
News, Downgrades, Analyst Ratings
JMP Securities Downgrades Allogene Therapeutics to Market Perform
5 Jan 24
News, Downgrades, Analyst Ratings
Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
5 Jan 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Thursday's After-Market Session
4 Jan 24
Movers
Allogene Therapeutics Partners With Foresight Diagnostics To Develop MRD-Based In-Vitro Diagnostic For Use In ALPHA3, For Frontline Consolidation In Large B-Cell Lymphoma
4 Jan 24
Biotech, News, General
Allogene Therapeutics Says The Refined Approach Of The 2024 Platform Vision Results In A Streamlined Trial Footprint As Well As A Focused Pipeline Prioritization, Allowing The Company To Implement A Planned Restructuring Of Resources In Q1 2024
4 Jan 24
News, Guidance
Allogene Therapeutics Announces 2024 Platform Vision To Redefine The Future Of CAR T Led By ALPHA3, the Industry's First Pivotal Trial For Frontline Consolidation In Large B-Cell Lymphoma
4 Jan 24
Biotech, News, General
Press releases
Allogene Therapeutics and Arbor Biotechnologies Announce Global Gene Editing Licensing Agreement to Support Advancement of Next-Generation Allogeneic CAR T Platform in Autoimmune Disease
12 Mar 24
Press Releases
Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update
5 Mar 24
News, Press Releases
Allogene Therapeutics Announces Participation in the 44th Annual TD Cowen Health Care Conference
28 Feb 24
News, Press Releases
Allogene Therapeutics to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments Related to the December 2020 Formation of the Allogene Overland Biopharm Joint Venture in Asia
16 Feb 24
Press Releases
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
16 Jan 24
News, Press Releases
Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma
4 Jan 24
Health Care, Press Releases
Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, the Industry's First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma
4 Jan 24
News, Health Care, Press Releases
Allogene Therapeutics to Host Conference Call Previewing its 2024 Platform Vision and Present at the 42nd Annual J.P. Morgan Healthcare Conference
3 Jan 24
News, Press Releases